Survival and quality‐of‐life implications of cytopenia trajectories in ruxolitinib‐treated myelofibrosis

These findings highlight the prognostic significance of cytopenia dynamics during ruxolitinib therapy and support the use of cytopenia trajectory monitoring as a valuable tool for risk stratification and treatment optimization in myelofibrosis.

Authors

Institutions

Publication Details

Journal
Cancer
Published
2026-02-13
DOI
https://doi.org/10.1002/cncr.70320
Primary Topic
Myeloproliferative Neoplasms: Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Survival and quality‐of‐life implications of cytopenia trajectories in ruxolitinib‐treated myelofibrosis

C. Sartor, Costanza Bosi, M. Bocchia, E. Abruzzese et al.
Cancer
Myeloproliferative Neoplasms: Diagnosis and Treatment
article

Survival and quality‐of‐life implications of cytopenia trajectories in ruxolitinib‐treated myelofibrosis

C. Sartor, Costanza Bosi, M. Bocchia, E. Abruzzese, Eloise Beggiato, A. Duminuco, Alessandro Isidori, Erika Morsia, G. A. Palumbo, Filippo Branzanti, Farina Mirko, Alessandra Dedola, Gianni Binotto, Bruno Martino, Roberto Massimo Lemoli, Daniele Cattaneo, Giovanni Caocci, Alessandra Iurlo, Massimiliano Bonifacio, Fabrizio Pane, Francesca Palandri, Giulia Benevolo, Novella Pugliese, Florian H. Heidel, Elena M. Elli, Daniela Cilloni, Francesco Cavazzini, Emilia Scalzulli, Alessia Tieghi, Mario Tiribelli, Monica Crugnola, Massimo Breccia
article en

Abstract

These findings highlight the prognostic significance of cytopenia dynamics during ruxolitinib therapy and support the use of cytopenia trajectory monitoring as a valuable tool for risk stratification and treatment optimization in myelofibrosis.

CancerVol. 132(4)
University of Siena (IT), University of Verona (IT), Marche Polytechnic University (IT), University of Udine (IT), University of Padua (IT), University of Cagliari (IT), University of Ferrara (IT), Policlinico Umberto I (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Medizinische Hochschule Hannover (DE), University of Catania (IT), Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT), Azienda Sanitaria Unità Locale di Reggio Emilia (IT), Azienda ospedaliera "Bianchi-Melacrino-Morelli" (IT), Azienda Unità Sanitaria Locale Piacenza (IT), Azienda Ospedaliera San Gerardo (IT), Federico II University Hospital (IT), Istituto di Ematologia di Bologna (IT), Policlinico Universitario di Catania (IT), Azienda Ospedaliera Universitaria Senese (IT), Ospedale di Parma (IT), Tecnologie Avanzate (Italy) (IT), St. Eugenio Hospital (IT), Ospedale Policlinico San Martino (IT), Gruppo Italiano per il Trapianto di Midollo Osseo (IT), University of Turin (IT), University of Brescia (IT), University of Genoa (IT), University of Bologna (IT)
Ministero della Salute
No poverty
Openalex Percentile: Top 57%
Myeloproliferative Neoplasms: Diagnosis and Treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.